Page last updated: 2024-10-25

eflornithine and Congenital Adrenal Hyperplasia

eflornithine has been researched along with Congenital Adrenal Hyperplasia in 3 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female."2.61Hirsutism in Women. ( Bain, J; Matheson, E, 2019)
"Hirsutism is defined as excess hair growth in androgen-dependent areas of the body in women."2.46Hirsutism: Diagnosis and management. ( Brodell, LA; Mercurio, MG, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matheson, E1
Bain, J1
Brodell, LA1
Mercurio, MG2

Reviews

3 reviews available for eflornithine and Congenital Adrenal Hyperplasia

ArticleYear
Hirsutism in Women.
    American family physician, 2019, 08-01, Volume: 100, Issue:3

    Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Antineoplastic Agents, Hormonal; Contraceptiv

2019
Hirsutism: Diagnosis and management.
    Gender medicine, 2010, Volume: 7, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diag

2010
Hirsutism: diagnosis and management.
    The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia, 2001, Volume: 4, Issue:2

    Topics: Adrenal Hyperplasia, Congenital; Androgens; Contraceptives, Oral; Eflornithine; Enzyme Inhibitors; F

2001